Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Fulcrum Therapeutics, Inc. (FULC) had Return on Investments of -5.67% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-18.89M |
|
-- |
|
-- |
|
$22.19M |
|
$-22.19M |
|
$3.29M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-18.89M |
|
$-22.19M |
|
$-21.85M |
|
76.22M |
|
76.22M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$338.67M |
|
$2.49M |
|
$8.10M |
|
$346.77M |
|
$9.86M |
|
-- |
|
$3.60M |
|
$13.47M |
|
$333.30M |
|
$333.30M |
|
$333.30M |
|
66.61M |
|
| Cash Flow Statement Financials | |
$-18.75M |
|
$-128.21M |
|
$-0.31M |
|
$198.73M |
|
$51.46M |
|
$-147.27M |
|
$3.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
34.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.67% |
|
-5.67% |
|
-5.45% |
|
|
Return on Investments |
-5.67% |
$5.00 |
|
$-0.25 |
|
$-0.25 |
|